News

The patent covers all compositions of matter and methods of use for NVC-612 and related compounds. NovaBay said that the new patent will broaden protection for NovaBay’s Aganocide

Earlier, on July 12, 2010, Endo Pharma has acquired HealthTronics through a tender offer and subsequent merger upon which HealthTronics became a wholly owned subsidiary of Endo Pharma.

The new research is expected to be conducted in Samsung Medical Center in Seoul. Pfizer said that it expanded into the market for targeted anticancer agents with the

Biotage said that based on high-performance, Molecularly Imprinted Polymers (MIPs), the 4 different screening plates deliver 128 selective resins. Biotage said that it would provide professional MIPs technical

As per the terms of the merger agreement, Carlyle is expected to acquire all of the outstanding common shares of NBTY for $55 per share in cash, representing

Voreloxin is an anticancer quinolone derivative (AQD), a class of compounds that has not been used previously for the treatment of cancer, where as Cytarabine is the standard-of-care

Merck agreed to acquire Millipore on February 28, 2010 for $107 in cash per share of Millipore common stock. The closing follows the approval of the acquisition by

Immucor’s HEA BeadChip product, through its multiplex DNA analysis, performs extended typing of 32 red blood cell antigens simultaneously. The CE mark covers all antigens tested by the

As per the agreement, Lonza is expected to support process scale-up, technology transfer, validation, and commercial manufacturing at one of its facilities in the US. Lonza was optimised